Newspaper Advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026

STUDDS ACCESSORIES LIMITED REGD. OFF.: PLOT NO. 918, SECTOR-68 IMT FARIDABAD-121004, HARYANA (INDIA) PHONES: 91-129-4296500 E mail : sales@studds.com, info@studds.com, secretarial@studds.com CIN No.: L25208HR1983PLC015135 Date: August 09, 2026 To, To, National Stock Exchange of India Ltd., BSE Limited Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street Bandra (E), Mumbai — 400 051 Mumbai- 400001 NSE Scrip Symbol: STUDDS BSE Scrip Code: 544599 Subject: Newspaper Publication- Disclosure under Requlation 30 and _47 of the SEBI (Listing Obligations and Disclosure Requirements) Requlations, 2015 (“SEBI Listing Requlations” Dear Sirf Ma’am, Pursuant to Regulation 30 and Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 47 and any other applicable provisions of the said Regulations, please find the enclosed copies of the Newspaper Publications in connection with the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 as approved in the Board Meeting of the Company held on Saturday, August 08, 2026. The advertisements are published in Financial Express (English)- All India edition and Jansatta (Hindi)- Delhi Edition, today on August 09, 2026. The aforesaid Financial Results and newspaper publications thereon are also hosted on the website of the Company at www.studds.com under Investor Relations’ Section at https:/Awww.studds.com/investor-relations/financials This is submitted for your information & records. Thanking You, FOR STUDDS ACCESSORIES LIMITED ASHA MITTAL Company Secretary and Compliance Officer Sruong WWW.FINANCIALEXPRESS.COM SUNDAY, AUGUST 9, 2026 FE SUNDAY @gy AKUMs DRUGS AND PHARMACEUTICALS LIMITED POWERICA POWERICA LIMITED CIN : LS1T00MH19S4PLO032825 CIN: L24239DL2004PLC 125888 a Registered Office : {h Floor, Bakhtawar, Nariman Poin, Mumbai - 400 024 Regd. Office: 304, 3° Floor, Mohan Place, L.S.C., Block-C, Saraswati Vihar, New Delhi-110034 (India) A PROMISE FOR POWER Tel No. +91 22 66562525, Email: investorrelations@powericalld.com, Website : vww.powericaltd.com Corporate Office: Akums House, Plot No. 131 to 133, Block-C, Mangolpuri Ind. Area, Phase-|, Delhi-110083 4 Akums Phone: +91-11-69041000, Fax: +91-11-27023256, E-mail: akumsho@akums.net, Website: www.akums.in EXTRACT OF STATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 Rs. in Crores Sr. Quarter Ended Year Ended UNAUDITED (STANDALONE & CONSOLIDATED) No. Particulars June 30, 2026| March 31, 2026| June 30, 2025| March 31, 2026 FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 |_[Uevauditen) | (Audited) | (Unaudited) | (Audited) _| 1 Revenue from Operations 780.11 #01,15 675.89 4,011.52 The Board of Direct f Ak D d Ph ticals Limited (“the C m 2 | Net Profit Before Share of Proof fAssiocilate 4.99 45.46 7.85 276.60 e Board of Directorso f Akums Drugs an armaceuticals Limite e Company”), a ES SIE PSR EAD Sake TERRa SS ESS | eae | eal Soe | eee | on recommendation of the audit committee, at its meeting held on August 8, 2026 For more information, : bit A a hal ae coll coe | ee oe | a | i g g ” : please scan: 4 Net Profit for the period (after Tax and exceptional items) | B4 43 | 45.14 | 30.59 | 277.31 | approved the Unaudited (Standalone & Consolidated) Financial Results for the Quarter 5 Total Comprehensive income for the period, net of tax. attributable to the 63.18 41.88 40.84 25.79 ended June 30, 2026. owners of the Company | | | | | The full Financial Results along with the Limited Review Report are available on the websites [a] [m] 6 | Paid-up equity aie capital (Face ake Rs. 5 each) | 63.28 | 63.28 | oat | 63.28 | of the stock exchanges at www.bseindia.com and www.nseindia.com, and also postedonthe am ae ethos ally (ine ing Nome eelins Wbocsicl 1 | |. Ee 1340.53: . op . . 8 | Earnings per share of Face Value of Rs, 5/- each 4.99 3.82 4.46 24.40 website of the Company and can be accessed at www.akums.in/investors/financial-report/. Basic & Diluted (Rs.) For Akums Drugs and Pharmaceuticals Limited | EXTRACT OF STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 Sd/- Sd/- | __Rs. in Crores Date: August 8, 2026 Sanjeev Jain Sandeep Jain Sr. Quarter Ended Year Ended Place: Delhi Managing Director Managing Director No, Particulars June 30, 2026 | March 31, 2026 June 30,2025 | March 34, 2026 _ (Unaudited) | (Audited) | (Unaudited) | (Audited) | | Revenue from Operations | 128.27 | 718.70 | 531 | 2594-09 | 2 Net Profit for the penod (before Tax and exceptional items) | 79.03 | S08 | 66.39 | 19T_40| 4 | Net Profit for the period {aller Tax and exceptionalitems} | 59.95 | d4.28 | 4459 | 201.83 | SiMe 4 | Total Comprehensive Income for ihe period, net of tax, attibutable to the 60.08 33.63 at2i 20012 Lowners of ihe Company | | | | | STUDDRSIDE YAOUCR DCREAEMSS SORIES LIMITED 15 Ppaied-cuap neq uityn sahasrea ca ptital (Facae value tRs. 5!- e ach) a 63.28 | a 63.28 | 54.41 | 63.28 | CIN: L25208HR1983PLC015135 7 | SEarnaingas pger sh arae o f Face Value of Rs, 5/- each 475 | 3.07 | 379 tha Registered and Corporate Office: Plot No. 918, Sector 68, IMT, Faridabad— 121004, Haryana oh in oe : Theoden tonelat AIT ARK Teaneaue a iresull . 7 eon iy a one - dais het k Phone No.: 91-129-4296500 | Website: www.studds.com | E-mail: secretarial@studds.com 2 above 5 af extinct oO) ie delal OTL OF Lita Naaione an COnStidaled Minancial TeSuils tor he Quarter ef ie URE U, The Wy! B.3lo6 | | Exchanges under Requlalian 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2075 including amendments thereunder, The full STATEMENT OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL format of the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026 are available on the Stock Exchange websites at weiw.bseindia.comand www.nseindia,com and on the Company's website atwww.powericaslctadm RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 Il The Group's main activity consists of Generator Set Business and Wind Power Business. Segment reporting is included in unaudited consolidated financial results. The Board of Directors of the Company, at its meeting held on August 08, 2026, approved the il Figuras forthe pervious periods have been regrauped/reclassifiatdo confotor thme classification of current periods. Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, I! The above extracotf unaudited standalone and consolidated financial results for the quarter ended Jume 30,2026 have been reviewed by the Audit Committee and You can view the Financial Results along with the Limited Review Reports by scanning this OR code approved by the Board of Diractors.at its meeting hald onugust 07,2026; The statutory auditor have carried out limited review of the unaudited financial results for or by visiting the website of Stock Exchange(s) - BSE (www.bseindia.com) and NSE (www.nseindia. the quarterended June 30. 2026. com) and on the Company's website at: htips://iwww.studds.com/investor-relations/financials. By Order of the Board For Powerica Limited By order of the Board el For STUDDS ACCESSORIES LIMITED tela aahaleg Sal Place - Mumbai Chairman & Managing Director 4) : Date - August 07, 2026 DIN: 00083664 =| Sidhartha Bhushan Khurana . 4) Place : Faridabad Managing Director e se sage motion isinaccardance with Pequlaton 47 ofthe SEB! (Listing Obfigations & Disclosure Requirements) (formerly known as Hari and Company Investments Madras Limited, and Se TS eke he Hari and Company Investments Madras Private Limited) Regd. Office: Prestige Zackria Metropolitan, No. 200/1-8, 8th Floor, Block -1, Anna Salai, Chennai - 600002. ay . . (CIN - U65991TN1989PL7C06061) , a enzymes Advanced Enzyme Technologies Limited Statement of Unaudited Financial Results for the quarter ended 30 June 2026 SS ar a a = CIN No.: L24200MHT98SPL0051018 [Reg [Showing first 8,000 characters — download PDF for full document]